d16 reduces tumor growth and overcomes therapeutic resistance in mutant p53-bearing cancers
The researchers combined computational and experimental approaches that led to the discovery of d16 and its potential anti-cancer activity.
Read MoreThe researchers combined computational and experimental approaches that led to the discovery of d16 and its potential anti-cancer activity.
Read MoreMicroscopic details of a newborn mouse eye showing blood vessels (pink) and macrophage immune cells (green).
Read MorePARMESAN scans public biomedical literature databases, identifies and ranks gene-gene and drug-gene regulatory relationships and even leverages curated information to predict undiscovered relationships.
Read MoreThis study reveals new insights into how the Zika virus sets up a niche in the placenta at the maternal-fetal interface.
Read MoreThis experimental model is a valuable tool to study how DEE44 develops and test potential therapies.
Read MoreSix Baylor College of Medicine faculty members were selected as recipients of the 2023 Michael E. DeBakey Excellence in Research Award.
Read MoreOxytocin drives the development and synaptic integration of new neurons within the adult mouse brain contributing to brain plasticity.
Read MoreThis study opens exciting new therapeutic avenues with the potential to alleviate and treat neurological issues that are currently untreatable.
Read MoreThis work is a clear example of how live tissue sensing can improve patient care.
Read MoreBy leveraging the team’s expertise in fruit fly biology and collaborating with clinicians, geneticists and genetic counselors the program aspires to provide answers to patients with severe undiagnosed conditions.
Read More